Wednesday, October 14, 2026

Less Than Two Hours Before The NASDAQ Open, Xcel Energy Is Down By 4%

Less Than Two Hours Before The NASDAQ Open, Xcel Energy Is Down By 4%

(VIANEWS) - The NASDAQ opens in less than two hours and Xcel Energy's pre-market value is already 4.91% down.

Xcel Energy's last close was $67.24, 13.42% under its 52-week high of $77.66.

The last session, NASDAQ ended with Xcel Energy (XEL) falling 0.1% to $67.24. NASDAQ jumped 2.48% to $11,717.28, after four sequential sessions in a row of gains, on what was an all-around bullish trend exchanging session.

About Xcel Energy

Xcel Energy Inc., through its subsidiaries, generates, purchases, transmits, distributes, and sells electricity. It operates through Regulated Electric Utility, Regulated Natural Gas Utility, and All Other segments. The company generates electricity through coal, nuclear, natural gas, hydroelectric, solar, biomass, oil, wood/refuse, and wind energy sources. It also purchases, transports, distributes, and sells natural gas to retail customers, as well as transports customer-owned natural gas. In addition, the company develops and leases natural gas pipelines, and storage and compression facilities; and invests in rental housing projects, as well as procures equipment for the construction of renewable generation facilities. It serves residential, commercial, and industrial customers in the portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. The company sells electricity to approximately 3.7 million customers; and natural gas to approximately 2.1 million customers. Xcel Energy Inc. was incorporated in 1909 and is headquartered in Minneapolis, Minnesota.

Earnings Per Share

As for profitability, Xcel Energy has a trailing twelve months EPS of $2.9.

PE Ratio

Xcel Energy has a trailing twelve months price to earnings ratio of 23.19. Meaning, the purchaser of the share is investing $23.19 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.85%.

Sales Growth

Xcel Energy's sales growth is 2.7% for the ongoing quarter and negative 4.2% for the next.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Dec 27, 2022, the estimated forward annual dividend rate is 1.95 and the estimated forward annual dividend yield is 2.87%.

Volume

Today's last reported volume for Xcel Energy is 4209496 which is 0.67% below its average volume of 2629140.

Yearly Top and Bottom Value

Xcel Energy's stock is valued at $67.24 at 08:14 EST, way below its 52-week high of $77.66 and way higher than its 52-week low of $56.89.

More news about Xcel Energy (XEL).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com